EMATAG

OVERVIEW

The Europe, Middle East, and Africa Technical Advisory Group (EMATAG) expanded its reach to Africa in 2011. The group, formally known as the Middle East and Europe Technical Advisory Group (MEETAG), originally met in 1997 as ETAG (European Technical Advisory Group). 

The purpose of the group is to:  

  • Enhance and expand the ISBT 128 Standard for use with blood components in Europe, the Middle East, and Africa;

  • Provide advice and support to facilities introducing the ISBT 128 Standard;

  • Generate, review, and comment upon proposed changes to the ISBT 128 Standard and its supporting documents;

  • Prepare educational material and tools to support the implementation of ISBT 128; and   

  • Promote the adoption of the ISBT 128 Standard in their region as well as globally. 

SUMMARY OF RECENT ACTIVITY

Mario Muon concluded his term as Chair of Europe, Middle East, & Africa Technical Advisory Group (EMATAG). Jolanta Antoniewicz-Papis was appointed as the new Chair.

 

EMATAG discussed the role of ISBT 128 beyond labeling- this includes standardized terminology, reference tables, and standardized electronic messages for the transfer of MPHO product information from one facility to another. ICCBBA has produced major work products correlated with moving beyond the label including ST-020 – ISBT 128 Standard for XML Electronic Messaging; ST-026 – ISBT 128 Standard for the Medical Products of Human Origin (MPHO) Unique Identifier; ST-027 – ISBT 128 Standard ISBT 128 Dictionary of Standard Data Elements IG-048 – Implementation Guide: MPHO Unique Identifier; BiologicallyDerivedProduct – HL7 FHIR/USCDI.

 

In 2021, ICCBBA published the ST-023 ISBT 128 Standard for Base Labels-this document includes specifications on the standardized placement of the 2-D Symbol on the base label and the standardized placement of linear bar codes on the base label. The linear bar code specifications were previously on the ISBT 128 Standard Labeling of Blood Components (ST-005) and ISBT 128 Standard Labeling of Cellular Therapy Products (ST-004).

 

The group discussed creating an International Blood TAG. The blood products category is the only area that currently does not have a TAG dedicated to the global focus on blood. The regional blood TAGs (such as EMATAG) would continue to have a regional focus while the International Blood TAG would focus on issues such as standardized terminology. This standardization can facilitate the process of shipping products from country to country.

EMATAG MEMBER LIST

Chair

  • Jolanta Antoniewicz-Papis

Representatives

  • Laila Al-Shaer - UAE

  • Önder Arslan - Turkey

  • Heidi Goubran - Egypt

  • Sveinn Gudmundsson - Iceland

  • Galina Hanstein - Estonia

  • Dinie Hoentjen - The Netherlands

  • Gerhard Kurt - Switzerland

  • Mario Muon - Portugal

  • Jerry Orlin - Israel

  • Reem Al Radwan - Kuwait

  • TBD - United Kingdom

  • Zoe Sidera - Cyprus

  • Kevin Valletta - Malta

Technical Experts

  • Jørgen Georgsen

  • Stella Larsson

  • Antonio Salat

Liaisons

  • EBA - European Blood Alliance

  • Christian Hay - GS1

Observers

  • Michael Angue

  • Fred Auwema

  • Denise Borg-Aquilina

  • Piotr Bratek

  • Aurélie Delos

  • Stephen Henry

  • Kent Kirimli

  • Raj Kumar

  • Laurence Marie

  • Anna Mårtensson

  • Wayne Miller

  • Stuart Morris

  • John Muircroft

  • Ana Negrão 

  • Sarah Richardson

  • Renata Rocha

  • Jean-Paul Roger

  • Bruno Rousselin

  • Stephane Sajot

  • Leif Sandvik

  • Rosanne Scerri

  • Serge Tabet

  • Susan Tibedo

  • Daniel Waurzyniak

  • Daniel Wiman

  • Will Willman

  • Bruce Wray

ICCBBA Staff Liaison

  • Erwin Cabana